Vivanza Biosciences Ltd

Vivanza Biosci. Summary Chart Analysis Peers Quarters Profit & Loss Balance Sheet Cash Flow Ratios Investors Documents

Vivanza Biosciences Ltd

₹ 2.71 -1.09%
23 May - close price
vivanzabiosciences.com BSE: 530057
About

Incorporated in 2016, Vivanza Biosciences
Ltd is in the business of Pharmaceutical Products

Key Points

Business Overview:[1]
Vivanza Biosciences Limited is a specialty pharma company focused on commercializing novel and generic pharmaceuticals, developing oral drug delivery systems, and having expertise in complex oral and topical dose forms including highly potent compounds, modified release products & injections

Website BSE
  • Market Cap ₹ 10.8 Cr.
  • Current Price ₹ 2.71
  • High / Low ₹ 7.20 / 1.90
  • Stock P/E
  • Book Value ₹ 0.99
  • Dividend Yield 0.00 %
  • ROCE -2.77 %
  • ROE -15.6 %
  • Face Value ₹ 1.00
Edit ratios

Pros

Cons

  • Stock is trading at 2.74 times its book value
  • Company has low interest coverage ratio.
  • The company has delivered a poor sales growth of -4.94% over past five years.
  • Promoter holding is low: 20.0%
  • Company has a low return on equity of 3.85% over last 3 years.
  • Company might be capitalizing the interest cost
  • Company has high debtors of 396 days.
  • Promoter holding has decreased over last 3 years: -27.8%
  • Working capital days have increased from 226 days to 415 days

* The pros and cons are machine generated. Pros / cons are based on a checklist to highlight important points. Please exercise caution and do your own analysis.

Peer comparison

Sector: Pharmaceuticals Industry: Pharmaceuticals - Indian - Bulk Drugs & Formln

Edit Columns
Loading peers table ...

Quarterly Results

Consolidated Figures in Rs. Crores / View Standalone

Mar 2022 Jun 2022 Sep 2022 Dec 2022 Mar 2023 Jun 2023 Sep 2023 Dec 2023 Mar 2024 Jun 2024 Sep 2024 Dec 2024 Mar 2025
5.85 2.35 1.35 5.86 8.24 9.23 7.62 6.56 4.42 2.44 3.00 1.50 0.48
5.95 2.23 1.38 5.30 8.23 8.64 7.30 6.27 4.56 2.08 2.89 1.37 1.44
Operating Profit -0.10 0.12 -0.03 0.56 0.01 0.59 0.32 0.29 -0.14 0.36 0.11 0.13 -0.96
OPM % -1.71% 5.11% -2.22% 9.56% 0.12% 6.39% 4.20% 4.42% -3.17% 14.75% 3.67% 8.67% -200.00%
0.00 0.05 0.30 0.01 0.12 0.01 0.05 0.02 -0.03 0.00 0.00 0.01 0.05
Interest 0.10 0.10 0.10 0.11 0.11 0.11 0.11 0.10 0.09 0.09 0.09 0.09 0.08
Depreciation 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.01 0.00 0.00 0.00 0.00
Profit before tax -0.20 0.07 0.17 0.46 0.02 0.49 0.26 0.21 -0.27 0.27 0.02 0.05 -0.99
Tax % 0.00% 0.00% 0.00% 0.00% 600.00% 0.00% 0.00% 0.00% 55.56% 0.00% 0.00% 0.00% 1.01%
-0.20 0.07 0.17 0.46 -0.10 0.49 0.26 0.21 -0.41 0.27 0.02 0.04 -1.00
EPS in Rs -0.05 0.02 0.04 0.12 -0.02 0.12 0.06 0.05 -0.10 0.07 0.00 0.01 -0.25
Raw PDF

Profit & Loss

Consolidated Figures in Rs. Crores / View Standalone

Mar 2016 Mar 2017 Mar 2018 Mar 2019 Mar 2020 Mar 2021 Mar 2022 Mar 2023 Mar 2024 Mar 2025
0.00 3.46 6.44 2.66 9.56 9.89 10.39 17.81 27.84 7.42
0.06 3.77 5.84 2.68 9.90 9.80 10.45 17.14 26.76 7.78
Operating Profit -0.06 -0.31 0.60 -0.02 -0.34 0.09 -0.06 0.67 1.08 -0.36
OPM % -8.96% 9.32% -0.75% -3.56% 0.91% -0.58% 3.76% 3.88% -4.85%
0.00 0.04 0.00 0.00 0.57 0.51 0.83 0.48 0.05 0.06
Interest 0.00 0.04 0.37 0.42 0.44 0.47 0.43 0.43 0.42 0.35
Depreciation 0.00 0.00 0.00 0.00 0.00 0.01 0.01 0.00 0.01 0.01
Profit before tax -0.06 -0.31 0.23 -0.44 -0.21 0.12 0.33 0.72 0.70 -0.66
Tax % 0.00% 0.00% 13.04% 0.00% 0.00% 41.67% 0.00% 16.67% 21.43% 1.52%
-0.06 -0.31 0.21 -0.44 -0.21 0.08 0.33 0.60 0.55 -0.67
EPS in Rs -0.32 -0.08 0.05 -0.11 -0.05 0.02 0.08 0.15 0.14 -0.17
Dividend Payout % 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Compounded Sales Growth
10 Years: %
5 Years: -5%
3 Years: -11%
TTM: -73%
Compounded Profit Growth
10 Years: %
5 Years: %
3 Years: %
TTM: -222%
Stock Price CAGR
10 Years: 15%
5 Years: %
3 Years: -48%
1 Year: -61%
Return on Equity
10 Years: %
5 Years: 5%
3 Years: 4%
Last Year: -16%

Balance Sheet

Consolidated Figures in Rs. Crores / View Standalone

Mar 2016 Mar 2017 Mar 2018 Mar 2019 Mar 2020 Mar 2021 Mar 2022 Mar 2023 Mar 2024 Mar 2025
Equity Capital 0.19 4.00 4.00 4.00 4.00 4.00 4.00 4.00 4.00 4.00
Reserves -0.16 -0.47 -0.27 -0.71 -0.92 -0.84 -0.51 0.09 0.64 -0.04
0.50 0.90 1.32 1.48 0.39 0.36 5.51 8.00 5.17 8.65
0.11 2.73 5.10 6.33 8.89 4.93 6.56 10.39 9.69 3.84
Total Liabilities 0.64 7.16 10.15 11.10 12.36 8.45 15.56 22.48 19.50 16.45
0.00 2.31 2.31 2.31 2.31 2.32 2.32 2.31 2.34 2.33
CWIP 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Investments 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
0.64 4.85 7.84 8.79 10.05 6.13 13.24 20.17 17.16 14.12
Total Assets 0.64 7.16 10.15 11.10 12.36 8.45 15.56 22.48 19.50 16.45

Cash Flows

Consolidated Figures in Rs. Crores / View Standalone

Mar 2016 Mar 2017 Mar 2018 Mar 2019 Mar 2020 Mar 2021 Mar 2022 Mar 2023 Mar 2024 Mar 2025
0.00 -2.07 -0.09 0.86 2.98 -3.08 2.47 -0.95 2.04 -2.50
0.00 1.90 0.00 0.00 0.00 -0.02 0.00 0.00 -0.04 -0.01
0.00 0.39 -0.55 -0.89 -2.75 2.80 -2.48 1.03 -1.98 2.46
Net Cash Flow 0.00 0.23 -0.64 -0.03 0.22 -0.30 -0.01 0.09 0.03 -0.05

Ratios

Consolidated Figures in Rs. Crores / View Standalone

Mar 2016 Mar 2017 Mar 2018 Mar 2019 Mar 2020 Mar 2021 Mar 2022 Mar 2023 Mar 2024 Mar 2025
Debtor Days 266.89 287.35 782.14 249.70 230.66 275.42 255.77 151.30 396.48
Inventory Days 215.20 150.49 309.32 38.07 25.93 91.82 54.64 28.27 120.95
Days Payable 304.36 319.46 878.47 319.47 153.98 207.06 211.26 115.76 140.22
Cash Conversion Cycle 177.72 118.38 212.99 -31.71 102.61 160.18 99.15 63.81 377.22
Working Capital Days 388.21 281.12 592.78 116.07 117.36 204.81 184.86 77.09 414.68
ROCE % -10.48% 12.66% -0.41% 5.58% 16.88% 12.14% 10.91% 10.23% -2.77%

Shareholding Pattern

Numbers in percentages

Jun 2022Sep 2022Dec 2022Mar 2023Jun 2023Sep 2023Dec 2023Mar 2024Jun 2024Sep 2024Dec 2024Mar 2025
47.80% 47.80% 47.80% 47.80% 47.80% 47.29% 44.90% 43.24% 40.05% 39.86% 20.02% 20.02%
52.20% 52.20% 52.20% 52.20% 52.20% 52.70% 55.10% 56.75% 59.95% 60.13% 79.98% 79.98%
No. of Shareholders 4,6364,6624,6744,8724,8675,0395,9376,99216,94116,70120,63520,833

Documents

Announcements

Annual reports